Fecal microbiota transplantation for vancomycin-resistant Clostridium innocuum infection in inflammatory bowel disease: A pilot study evaluating safety and clinical and microbiota outcome
Single-dose FMT appears to be a safe and feasible therapeutic approach for refractory or recurrent C. innocuum infections in IBD patients, with potential benefits in disease activity and microbiome restoration. Further studies are warranted to optimize long-term outcomes.
Authors
- Yuan‐Ming Yeh (ORCID: https://orcid.org/0000-0001-8720-947X)
- Cheng‐Tang Chiu (ORCID: https://orcid.org/0000-0002-7437-8052)
- Puo‐Hsien Le (ORCID: https://orcid.org/0000-0002-1100-5371)
- Yung‐Kuan Tsou (ORCID: https://orcid.org/0000-0002-7254-7369)
- Cheng‐Hsun Chiu (ORCID: https://orcid.org/0000-0003-4324-7743)
- Chyi‐Liang Chen (ORCID: https://orcid.org/0000-0003-4591-0924)
- Chien‐Chang Chen (ORCID: https://orcid.org/0000-0002-2881-3973)
- Yi-Ching Chen (ORCID: https://orcid.org/0000-0003-1340-9510)
Institutions
- Chang Gung University of Science and Technology (TW)
- Chang Gung University (TW)
- Chang Gung Memorial Hospital (TW)
- Taoyuan Chang Gung Memorial Hospital (TW)
Publication Details
- Journal
- Journal of Microbiology Immunology and Infection
- Published
- 2025-03-04
- DOI
- https://doi.org/10.1016/j.jmii.2025.03.004
- Citations
- 2
- Primary Topic
- Clostridium difficile and Clostridium perfringens research
- Type
- article
- Field-Weighted Citation Impact
- 2.79
Funders
- Chang Gung Memorial Hospital